Multicenter, cluster-based, superiority trial of a multicomponent life-style intervention versus standard take care of lowering cardiometabolic danger in people with psychotic problems over 36 months: the LAGOM protocol

Background:

Cardiometabolic conditions-including heart problems, sort 2 diabetes, and obesity-are extremely prevalent amongst people with psychotic problems. These situations contribute considerably to lowered life expectancy, diminished high quality of life, and elevated societal and financial burdens. Thus, efficient, individualized interventions are urgently wanted. Outpatient psychiatric clinics provide a great setting for such efforts owing to common affected person contact and entry to multidisciplinary care. We have developed a complete, clinically built-in trial aimed toward enhancing cardiometabolic well being, selling more healthy existence, and enhancing high quality of life for people with psychotic problems receiving care within the Greater Gothenburg area.

Methods:

LAGOM is a multicenter, naturalistic, quasi-experimental case‒management trial carried out throughout six geographically separate outpatient psychosis clinics throughout the Department of Psychotic Disorders at Sahlgrenska University Hospital, a multi-site college hospital within the Greater Gothenburg area. A complete of 650 adults with psychotic problems will likely be recruited from these clinics. Two clinics will implement the LAGOM intervention, whereas 4 will function management websites delivering standard care. The intervention is embedded inside routine psychiatric care and grounded in behavioral science. It contains complete cardiometabolic danger assessments, two visible motivational instruments (QRISK3 and a physique composition analyzer), customized follow-up plans, risk-oriented referrals to major care, and structured schooling for sufferers, family, and employees. The intervention is designed to be scalable, sustainable, and tailor-made to particular person affected person wants.

Discussion:

If confirmed superior to standard care, this pragmatic, multicomponent intervention-delivered inside routine psychiatric care-could enhance cardiometabolic well being and high quality of life for people with psychotic problems. Embedding the intervention inside current scientific constructions enhances its scalability and feasibility and, if efficient, might function a mannequin for wider implementation.

Trial registration:

MedicalTrials.gov (NCT06781801; date registered: 16 January 2025).

Trial standing:

Recruitment began on 27 February 2025 and will likely be accomplished on 31 December 2026. The present scientific investigation plan model is 3.1, dated 21 October 2025.